Skip to main content
AGL
NYSE Industrial Applications And Services

agilon Swings to $35M Q3 Profit, Lifts 2026 Adjusted EBITDA Guidance to $145-$155M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$100
Mkt Cap
$1.616B
52W Low
$7.48
52W High
$133.04
52W Position info
1237% above low
Off High info
25% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AGL has more than doubled off its 52-week low of $7.48.

Summary

agilon health swung to $35 million of Q3 2026 net income from a $110 million loss and raised full-year Adjusted EBITDA guidance to $145-$155 million from $75-$95 million, even as platform membership fell 8%.


Key Events · Earnings and Guidance · AGL

  • Q3 Swing to $35M Net Income

    Net income was $35 million in Q3 2026 versus a net loss of $110 million in Q3 2025; Adjusted EBITDA was $64 million versus negative $91 million.

  • 2026 Adjusted EBITDA Guidance Raised

    Full-year 2026 Adjusted EBITDA guidance rose to $145-$155 million from $75-$95 million, and revenue guidance to $5.87-$5.89 billion from $5.775-$5.86 billion.

  • Medical Cost Ratio Improves Sharply

    The medical services expense ratio fell to 88.5% in Q3 2026 from 104.0% a year earlier, helped by favorable claims development in the first half of 2026.

  • Membership Still Contracting

    Total members on the platform fell 8% to 566,000 as of September 30, 2026, including 454,000 Medicare Advantage members, reflecting disciplined contracting and previously disclosed market exits.


Analysis · AGL · Industrial Applications And Services

The headline number is a $35 million net profit in Q3 2026, a sharp reversal from a $110 million loss a year earlier, with Adjusted EBITDA at $64 million versus negative $91 million. More consequential is the full-year outlook: Adjusted EBITDA guidance was raised to $145-$155 million from $75-$95 million, and revenue guidance to $5.87-$5.89 billion from $5.775-$5.86 billion. The medical services expense ratio fell to 88.5% from 104.0%, meaning the company is finally keeping more of each premium dollar after years of losses. Membership, however, is still shrinking — total members on the platform fell 8% to 566,000 — so the profit is coming from cost discipline and favorable claims development rather than growth. On the balance sheet, $312 million of cash and marketable securities against $32 million of debt leaves no near-term funding pressure.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AGL was trading at $100.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $7.48 to $133.04. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AGL - Latest Insights

AGL
Nov 04, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $96.23
Real-time Price: $88.59 info
Change: -$7.64 (-8%) info
Market Cap: $1.489B info
AGL
May 06, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $36.00
Real-time Price: $88.59 info
Change: +$52.59 (+146%) info
Market Cap: $1.489B info
AGL
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.56
Real-time Price: $88.59 info
Change: +$54.03 (+156%) info
Market Cap: $1.489B info
AGL
Apr 27, 2026, 4:21 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $25.40
Real-time Price: $88.59 info
Change: +$63.19 (+249%) info
Market Cap: $1.489B info
AGL
Apr 27, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.40
Real-time Price: $88.59 info
Change: +$63.19 (+249%) info
Market Cap: $1.489B info